Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life

International Journal of Women's Health

Volumn 10, Issue , 2018, Pages 195-201

  Al Shaikh, Ghadeer ^a   Syed, Sadiqa ^b   Osman, Somaia ^c   Bogis, Abdulrahman ^a   Al Badr, Ahmed ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b PRINCESS NOURAH BINT ABDULRAHMAN UNIVERSITY   (Saudi Arabia)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Nonsurgical intervention; Pessary; Urinary incontinence; Vaginal prolapse

Indexed keywords

ESTROGEN;

ABDOMINAL PRESSURE; BODY WEIGHT LOSS; CANADA; CONSERVATIVE TREATMENT; CONSTIPATION; DATA ANALYSIS; ELECTROSTIMULATION; FEMALE; HUMAN; MAGNETIC STIMULATION; MEDICAL DEVICE COMPLICATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MICTURITION DISORDER; PATIENT SATISFACTION; PELVIC FLOOR MUSCLE TRAINING; PESSARY EXPULSION; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; STRESS INCONTINENCE; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; VAGINA ATROPHY; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINA PAIN;

EID: 85049184817     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/IJWH.S152616     Document Type: Review

References (68)

1. Haylen BT, deRidder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26.
2. Minassian VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynecol Obstet. 2003;82:327–338.
3. Hunskaar S, Burgio K, Diokno A, Herzog AR, Hjälmås K, Lapitan MC. Epidemiology and natural history of urinary incontinence in women. Urology. 2003;62(Suppl 1):16–23.
4. Swift S, Woodman P, O’Boyle A, et al. Pelvic organ support study (POSST): the distribution, clinical definition and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192: 795–806.
5. Nygaard IE, Heit M. Stress urinary incontinence. Obstet Gynaecol. 2004; 104:607–620.
6. Waetjen LE, Subak LL, Shen H, et al. Stress urinary incontinence surgery in United States. Obstet Gynecol. 2003;101:671–676.
7. Stewart E. Treating urinary incontinence in older women. Br J Community Nurs. 2010;15:526–532.
8. DeMaagd GA, Davenport TC. Management of urinary incontinence. Pharm Therap. 2012;37:345–361.
9. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178.
10. Cheater FM, Castleden CM. Epidemiology and classification of urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14:183–205.
11. Harris SS, Link CL, Tennstedt SL, Kusek JW, McKinlay JB. Care seeking and treatment of urinary incontinence in a diverse population. J Urol. 2007;177:650–654.
12. Ptak M, Brodowska A, Ciećwież S, Rotter I. Quality of life in women with stage 1 stress urinary incontinence after application of conservative treatment—a randomized trial. Int J Environ Res Public Health. 2017;14(6):pii E577.
13. Dubeau CE, Simon SE, Morris JN. The effect of urinary incontinence on quality of life in older nursing home residents. J Am Geriatr Soc. 2006;54:1325–1333.
14. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101:1388–1395.
15. Serati M, Salvatore S, Uccella S, Nappi RE, Bolis P. Female urinary incontinence during intercourse: a review on an understudied problem for women’s sexuality. J Sex Med. 2009;6:40–48.
16. Buchsbaum GM. Urinary incontinence and pelvic organ prolapse. Minerva Urol Nefrol. 2006;58:311–319.
17. Hersh L, Salzman B. Clinical management of urinary incontinence in women. Am Fam Physician. 2013;87:634–640.
18. Norton P, Brubaker L. Urinary incontinence in women. Lancet. 2006; 367:57–67.
19. Gibbs CF, Johnson TM II, Ouslander JG. Office management of geriatric urinary incontinence. Am J Med. 2007;120:211–220.
20. Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360: 481–490.
21. Khan IJ, Tariq SH. Urinary incontinence: behavioral modification therapy in older adult. Clin Geriatr Med. 2004;20:499–509.
22. McIntosh L, Anderson E, Reekie M. Conservative treatment of urinary stress incontinence in women: a 10-year (2004–2013) scoping review of the literature. Urol Nurs. 2015;35:179–186.
23. Daman-Van Beek Z, Teunissen D, Dekker JH, et al. Practice guidelines ‘urinary incontinence in women’ from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd. 2016;160:D674.
24. Miller J, Ashton-Miller J, Delancey J. A pelvic muscle precontraction can reduce cough related urine loss in selected women with mild SUI. J Am Geriatr Soc. 1998;46:870–874.
25. Miller J, Sampselle C, Ashton-Miller J, Hong G, Delancey J. Clarification and confirmation of Knack maneuver: the effect of volitional pelvic floor muscle contraction to preempt expected stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:773–782.
26. Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment or inactive control treatment for urinary incontinence in women. Cochrane Database Syst Rev. 2010;(1):CD005654.
27. Borello-France D, Burgio KL, Goode PS, et al. Adherence to behavioral interventions for stress incontinence: rates, barriers, and predictors. Phys Ther. 2013;93:757–773.
28. Shamliyan T, Kane R, Wyman J, Wilt T. Systematic review: randomized controlled trials of non-surgical treatments for urinary incontinence in women. Ann Intern Med. 2008;148:459–473.
29. Frank C, Szlanta A. Office management of urinary incontinence among older patients. Can Fam Physician. 2010;56:1115–1120.
30. Shah SM, Sultan AH, Thakar R. The history and evolutions of pessaries for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunc. 2006;17:170–175.
31. Nygaard I. Prevention of exercise incontinence with mechanical devices. J Reprod Med. 1995;40:89–94.
32. Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014; 349:g4531.
33. Karon S. Conservative management of continence in women over the age of 65 years living in the community: a review. Aust NZ Cont J. 2009; 15:34–44.
34. Roehl B, Buchanan EM. Urinary incontinence evaluation and the utility of pessaries in older women. Care Manag J. 2006;7:213–217.
35. Komesu YM, Ketai LH, Rogers RG, Eberhardt SC, Pohl J. Restoration of continence by pessaries: magnetic resonance imaging assessment of mechanism of action. Am J Obstet Gynecol. 2008;198:563–566.
36. Towbridge ER, Fenner DE. Practicalities and pitfalls of pessaries in older women. Clin Obstet Gynecol. 2007;50:709–719.
37. Farrell SA, Baydock S, Amir B, Fanning C. Effectiveness of a new self-positioning pessary for the management of urinary incontinence in women. Am J Obstet Gynecol. 2007;196:474.e1–474.e8.
38. Viera AJ, Larkins-Pettigrew M. Practical use of the pessary. Am Fam Physician. 2000;61:2719–2726.
39. National Institute for Health and Care Excellence (NICE) [webpage on the Internet]. Urinary Incontinence: The Management of Urinary Incontinence in Women. CG171. London: Royal College of Obstetricians and Gynaecologists; 2013. Available from: www.nice.org.uk/ Guidance/CG171. Accessed August 6, 2017.
40. Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE. Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2004;15:302–307.
41. Jones KA, Harmanli O. Pessary use in pelvic organ prolapse and urinary incontinence. Rev Obstet Gynecol. 2010;3:3–9.
42. Nager CW, Richter HE, Nygaard I, et al. Incontinence pessaries: size, POPQ measures, and successful fitting. Int Urogynecol J. 2009;20: 1023–1028.
43. Cameron AP, Jimbo M, Heidelbaugh JJ. Diagnosis and office based treatment of urinary incontinence in adults. part two: treatment. Ther Adv Urol. 2013;5:189–200.
44. Ding J, Chen C, Song XC, Deng M, Zhu L. Changes in prolapse and urinary symptoms after successful fitting of a ring pessary with support in women with advanced pelvic organ prolapse: a prospective study. Urology. 2016;87:70–75.
45. Hanson LA, Schulz JA, Flood CG, Cooley B, Tam F. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patients characteristics and factors contributing to success. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:155–159.
46. Noblett KL, McKinney A, Lane FL. Effects of the incontinence dish pessary on urethral support and urodynamic parameters. Am J Obstet Gynecol. 2008;198:592.e1–592.e5.
47. Robert M, Mainprize TC. Long term assessment of incontinence ring pessary for the treatment of stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:302–307.
48. Farrell SA, Singh B, Aldakhil I. Continence pessaries in the management of urinary incontinence in women. J Obstet Gynecol Can. 2004;26: 113–117.
49. Maito JM, Quam ZA, Craig E, Danner KA, Rogers RG. Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health. 2006;51:78–84.
50. Robert M, Schulz JA, Harvey MA. Technical update on pessary use. J Obstet Gynecol Can. 2013;35:664–667.
51. Von Bargen E, Patterson D. Cost utility of the treatment of stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2015;21:150–153.
52. Sirls LT, Foote JE, Kaufman JM, et al. Long term effects of FemSoft urethral insert for the management of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:88–95.
53. United States Food and Drug Administration [webpage on the Internet]. Stress Urinary Incontinence (SUI). Available from: https://www.fda. gov/MedicalDevices/ucm284109.htm. Accessed August 7, 2017.
54. Maund E, Guski LS, Gøtzsche PC. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. Can Med Assoc J. 2017;189:E194–E203.
55. Krammerer-Doak D, Svabik K, Bazi T. Variability in practice patterns in stress urinary incontinence and pelvic organ prolapse: results of an IUGA survey. Int Urogynecol J. 2017;28:735–744.
56. Atnip SD. Pessary use and management for prlvic organ prolapse. Obstet Gynecol Clin North Am. 2009;36:541–563.
57. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010;115:609–617.
58. Bettez M, Tu LM, Carlson K, Corcos J, Jolivet M, Bailley G. 2012 Update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can Urol Assoc J. 2012;6:354–363.
59. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190:1025–1029.
60. Kenton K, Barber M, Wang L, et al. Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence. Female Pelvic Reconstr Surg. 2012;18:118–121.
61. Handa VL, Whitcomb E, Weidner AC, et al. Sexual function before and after non-surgical treatment for stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2011;17:30–35.
62. Fernando RJ, Thakar S, Sultan AH, Shah SM, Jones PW. Effect of vaginal pessaries on symptom associated with pelvic organ prolapse. Obstet Gynecol. 2006;108:93–99.
63. Brincat C, Kenton K, Fitzgerald MP, Brubaker L. Sexual activity predicts continued pessary use. Am J Obstet Gynecol. 2004;191:198–200.
64. Schaffer J, Nager CW, Xiang F, et al. Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence. Obstet Gynecol. 2012;120:91–97.
65. Lone F, Thakar R, Sultan AH. One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ_UI (SF) questionnaires. Int Urogynecol J. 2015;26:1305–1312.
66. Sullivan SA, Davidson ER, Bretschneider CE, Liberty AL, Geller EJ. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2016;27: 811–816.
67. Bash KL. Review of vaginal pessaries. Obstet Gynecol Surv. 2000;55: 455–460.
68. Sarma S, Ying T, Moore KH. Long term vaginal ring pessary use: discontinuation rates and adverse events. BJOG. 2009;116:1715–1721.